Estimating controlled direct treatment effects on pain intensity using structural mean models: application to pain randomized controlled trials

Analytical methods to incorporate potential concurrent analgesic use into primary statistical summaries are underutilized in pain randomized controlled trials (RCTs). Without valid inclusion of analgesic use, the primary analyses of pain may produce diminished estimated treatment effects. We used contemporary causal inference methods that can account for concurrent treatment to reanalyze RCT data examining the effect of epidural steroid injection (ESI). Specifically, we define an "attributable to ESI estimand", which is the controlled direct effect of ESI. We used a simple composite pain intensity outcome, the QPAC1.5, and structural mean models (SMM) to estimate the target estimand. Compared to traditional methods such as strict intention to treat analysis (strict ITT), SMMs can account for analgesic use without assuming sequential ignorability. We estimated treatment effects of ESI on leg pain intensity (LPI) using the numeric rating scale (NRS) with strict ITT, 3 SMM estimating methods (estimating equations [EE], g-estimation, and generalized method of moments [GMM]), and the QPAC1.5. The treatment effect of ESI on LPI using strict ITT was -0.751 NRS points (95% confidence interval [CI]: [-1.287, -0.214]). Estimates for the attributable to ESI estimand were -0.864 (95% CI: [-3.207, 1.478]) for EE, -0.935 (95% CI: [-1.779, 0.090]) for g-estimation, -0.653 (95% CI: [-1.218, -0.089]]) for GMM, and -0.930 (95% CI: [-1.508, - 0.352]) for the QPAC1.5. We illustrate how contemporary causal inference methods and alternative estimands can be used to account for concurrent analgesic use in pain RCTs, in a manner that may result in larger treatment effects.